Related references
Note: Only part of the references are listed.Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers
Yun Song et al.
CANCER (2020)
A systematic review of the international prevalence of BRCA mutation in breast cancer
Nigel Armstrong et al.
CLINICAL EPIDEMIOLOGY (2019)
Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
Zoe Kemp et al.
JAMA NETWORK OPEN (2019)
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
Masami Arai et al.
JOURNAL OF HUMAN GENETICS (2018)
Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
Wei Xiong Wen et al.
JOURNAL OF MEDICAL GENETICS (2018)
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
Christoph Engel et al.
BMC CANCER (2018)
Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls
Yukihide Momozawa et al.
NATURE COMMUNICATIONS (2018)
Association Between BRCA Status and Triple-Negative Breast Cancer: A Meta-Analysis
Haixia Chen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Karoline B. Kuchenbaecker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Role of Genetic Testing in Patients With Breast Cancer A Review
Olivia M. Valencia et al.
JAMA SURGERY (2017)
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes
Saundra S. Buys et al.
CANCER (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer
Nadine Tung et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer
Karin Kast et al.
JOURNAL OF MEDICAL GENETICS (2016)
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study
Eunyoung Kang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
Fergus J. Couch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population
Edward S. Y. Wong et al.
PLOS ONE (2015)
Frequency of Mutations in Individuals With Breast Cancer Referred for BRCA1 and BRCA2 Testing Using Next-Generation Sequencing With a 25-Gene Panel
Nadine Tung et al.
CANCER (2015)
Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal
P. Ghadirian et al.
CLINICAL GENETICS (2014)
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
Richard M. Brohet et al.
JOURNAL OF MEDICAL GENETICS (2014)
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Efrat Gabai-Kapara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia
Grazia Palomba et al.
ONCOLOGY LETTERS (2014)
Prevalence and Type of BRCA Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network
Jeffrey N. Weitzel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Allison W. Kurian
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for Hereditary Breast-Ovarian Cancer
Michael J. Hall et al.
CANCER (2009)
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting:: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
D. Gareth Evans et al.
BMC CANCER (2008)
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
A. C. Antoniou et al.
BRITISH JOURNAL OF CANCER (2008)
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
Kokichi Sugano et al.
CANCER SCIENCE (2008)
Variation of breast cancer risk among BRCA1/2 carriers
Colin B. Begg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
Deann P. Atchley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study
Antonino Musolino et al.
BREAST (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Genetic susceptibility to breast cancer
Angela R. Bradbury et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2007)
Characterization of BRCA1 and BRCA2 mutations in a large United States sample
SN Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The molecular pathology of hereditary breast cancer:: genetic testing and therapeutic implications
E Honrado et al.
MODERN PATHOLOGY (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling
MO Nicoletto et al.
CANCER TREATMENT REVIEWS (2001)
Share Paper
